Informed Consent: A Clinical Trials Perspective

Marilyn J. Hammer; Patricia A Eckardt; Margaret Barton-Burke

doi:10.1188/16.ONF.694-696

Informed Consent: A Clinical Trials Perspective

Marilyn J. Hammer, Patricia A Eckardt, Margaret Barton-Burke

Nursing

Mount Sinai Hospital

Producción científica: Article › revisión exhaustiva

Resumen

The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.

Idioma original	American English
Publicación	Oncology Nursing Forum
Volumen	43
DOI	https://doi.org/10.1188/16.ONF.694-696
Estado	Published - nov 2016

Disciplines

Education
Medicine and Health Sciences
Nursing

Acceder al documento

10.1188/16.ONF.694-696

Citar esto

@article{59b867a1eefa416f9c84fe696b66aaba,

title = "Informed Consent: A Clinical Trials Perspective",

abstract = " The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored. ",

keywords = "biology of cancer, ethics, genetics, nursing research",

author = "Hammer, \{Marilyn J.\} and Eckardt, \{Patricia A\} and Margaret Barton-Burke",

note = "The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a ...",

year = "2016",

month = nov,

doi = "10.1188/16.ONF.694-696",

language = "American English",

volume = "43",

journal = "Oncology Nursing Forum",

}

TY - JOUR

T1 - Informed Consent: A Clinical Trials Perspective

AU - Hammer, Marilyn J.

AU - Eckardt, Patricia A

AU - Barton-Burke, Margaret

N1 - The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a ...

PY - 2016/11

Y1 - 2016/11

N2 - The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.

AB - The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.

KW - biology of cancer

KW - ethics

KW - genetics

KW - nursing research

U2 - 10.1188/16.ONF.694-696

DO - 10.1188/16.ONF.694-696

M3 - Article

VL - 43

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

ER -